ADDF expands Alzheimer's diagnostic accelerator into digital space

With an additional $15 million in funding, the Alzheimer's Drug Discovery Foundation (ADDF) launched an initiative within its Diagnostics Accelerator program to advance the development of digital tools for Alzheimer's disease and related dementias.

The expanded research will explore "creative and cost-effective" tools to collect, track and analyze patient data at various stages of the disease...